Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 2.08 Billion

CAGR (2026-2031)

3.66%

Fastest Growing Segment

Food and Beverage

Largest Market

North America

Market Size (2031)

USD 2.58 Billion

Market Overview

The Global Cyclamate Market will grow from USD 2.08 Billion in 2025 to USD 2.58 Billion by 2031 at a 3.66% CAGR. Cyclamate is a high-intensity artificial sweetener chemically defined as the sodium or calcium salt of cyclamic acid, offering a sweetness level approximately 30 to 50 times greater than sucrose. The primary drivers supporting market growth include its superior stability during high-temperature processing, which makes it essential for baked goods, and its significant cost advantage over other synthetic alternatives. Furthermore, its synergistic capacity to mask the bitter aftertaste of compounds like saccharin encourages its widespread inclusion in diverse beverage and pharmaceutical formulations. According to the China Food Additives and Ingredients Association, in 2024, the industry trade platform featured over 1,500 exhibitors, reflecting the robust manufacturing capabilities and supply chain scale available to meet rising global demand.

Despite these favorable economic factors, the Global Cyclamate Market faces a significant challenge regarding regulatory inconsistency across different jurisdictions. The longstanding prohibition of the product by the United States Food and Drug Administration restricts access to a major North American consumer base and perpetuates historical safety concerns that can impede broader international adoption.

Key Market Drivers

The escalating prevalence of diabetes and obesity is a primary factor propelling the global cyclamate market, compelling manufacturers to reformulate products with zero-calorie alternatives. As public health organizations intensify their focus on sugar reduction, the food and beverage industry is aggressively adopting high-intensity sweeteners to mitigate the caloric density of their portfolios without compromising taste. According to the International Diabetes Federation, in 2024, approximately 589 million adults aged 20-79 were living with diabetes worldwide, creating a massive demographic necessity for low-glycemic dietary options. This health-driven shift is reflected in broader consumption patterns; according to Ingredion, in 2024, sales of packaged food and beverage products featuring reduced-sugar claims had grown by more than 30% since 2020, underscoring the commercial viability of cyclamate-sweetened formulations.

Simultaneously, the cost-effectiveness and price advantage of cyclamate over natural sweeteners and sugar remain a critical driver for its sustained industrial use. In price-sensitive markets and high-volume applications, such as carbonated soft drinks and confectionery, the sweetener's ability to deliver intense sweetness at a fraction of the cost of sucrose or stevia allows manufacturers to protect profit margins amidst fluctuating raw material prices. The market is supported by robust supply chain capabilities that ensure this economic advantage is maintained through economies of scale. For instance, according to Golden Time Chemical (Jiangsu) Co., Ltd., a major industry producer, in 2024, the company maintained an annual production capacity of 40,000 tons of sodium cyclamate, ensuring a stable and low-cost supply for global downstream buyers.

Download Free Sample Report

Key Market Challenges

The Global Cyclamate Market faces substantial headwinds due to the regulatory inconsistency across jurisdictions, most notably the longstanding prohibition by the United States Food and Drug Administration. This regulatory fragmentation hampers market growth by forcing manufacturers to develop dual product lines—one for regions where cyclamate is permitted, such as Europe and Asia, and another for the lucrative North American market. This necessity eliminates the economies of scale typically achieved through standardized global formulations, thereby increasing production costs and complicating supply chain logistics for multinational beverage and food corporations.

Furthermore, the exclusion from the United States market perpetuates historical stigma regarding the ingredient's safety profile, influencing consumer perception even in regions where it is approved. This reputational barrier directly affects consumption trends and deters potential adoption. According to the International Food Information Council, in 2024, 31% of U.S. consumers reported decreasing or stopping their consumption of low- and no-calorie sweeteners specifically because they heard they were unsafe. This data underscores how regulatory disapproval in a major economy sustains negative consumer sentiment, ultimately restricting the ingredient's broader international adoption and volume growth.

Key Market Trends

The Adoption of Synergistic Multi-Sweetener Blending Formulations is fundamentally reshaping the market as manufacturers increasingly pair cyclamate with other high-intensity sweeteners to create superior sensory profiles. While cyclamate is traditionally valued for its stability, the current market momentum is defined by its strategic combination with saccharin to mitigate the metallic aftertaste associated with single-sweetener use. This formulation trend received a critical commercial catalyst recently due to regulatory relaxations regarding its primary blending partner. According to the International Sweeteners Association, in 2024, the European Food Safety Authority re-confirmed the safety of saccharin and increased its Acceptable Daily Intake from 5 to 9 mg/kg body weight per day, a regulatory development that directly expands the permissible volume and application scope for these synergistic cyclamate-saccharin blends in the European food and beverage sector.

Simultaneously, the Rising Utilization as a Bitterness Masking Agent in Pharmaceuticals is driving specialized demand, particularly for pediatric and geriatric oral formulations where palatability determines therapeutic compliance. Pharmaceutical developers are aggressively integrating cyclamate-based excipients to neutralize the aversive taste profiles inherent in complex modern active pharmaceutical ingredients (APIs), moving beyond simple sweetening to functional taste modification. The urgency of this application is underscored by the high prevalence of palatability issues in drug development. According to the European Society of Medicine, October 2024, in the 'Medical Research Archives', a comprehensive retrospective analysis revealed that bitterness was the primary taste masking challenge for 65% of the drug actives studied, highlighting the critical and expanding necessity for cyclamate's specific receptor-blocking capabilities in new medicinal product launches.

Segmental Insights

The Food and Beverage sector represents the fastest-growing segment in the global cyclamate market, driven by increasing consumer demand for low-calorie and sugar-free alternatives. Manufacturers extensively utilize this sweetener due to its cost-effectiveness and high stability during heating processes, rendering it essential for producing baked goods, confections, and carbonated beverages. Additionally, established safety approvals from organizations such as the European Food Safety Authority facilitate its widespread application in regions seeking to reduce sugar consumption. This trend reflects a broader industry shift toward formulating healthier products without compromising taste or affordability.

Regional Insights

North America holds a prominent position in the Global Cyclamate Market, driven primarily by substantial consumption in Canada and Mexico where regulatory frameworks explicitly permit its use. Health Canada approves cyclamate as a tabletop sweetener and pharmaceutical excipient, supporting a robust market for sugar alternatives within the region. This regulatory endorsement facilitates widespread adoption in authorized jurisdictions, catering to a consumer base increasingly focused on calorie reduction and weight management. Consequently, the established food and pharmaceutical sectors in these permitted zones underpin North America’s significant market share, sustaining its leadership despite varying regulations across the continent.

Recent Developments

  • In December 2024, the National Health Commission of China officially approved the expanded use of sodium cyclamate in flavored fermented milk, marking a significant market breakthrough for the sweetener industry. This approval, announced under the commission's "Three New Foods" notice, allowed dairy manufacturers to incorporate the intense sweetener into a broader range of yogurt and fermented milk products. This regulatory development opened new avenues for sweetener producers to collaborate with dairy companies on innovative, low-calorie product formulations, directly addressing the growing consumer demand for sugar-reduced functional dairy options in the region.
  • In December 2024, the Singapore Food Agency directed the importer Yan Tai Yit Pte Ltd to recall a peanut product imported from China following the detection of cyclamate, which is not permitted for use in nut and seed categories under local food regulations. This specific recall highlighted the ongoing regulatory scrutiny regarding the unauthorized use of sodium cyclamate in non-approved food sectors. The event served as a critical reminder for food trading companies to rigorously verify product formulations against local food additive regulations to prevent disruptions in the commercial distribution of processed foods.
  • In October 2024, the Singapore Food Agency (SFA) issued a recall for a specific batch of melon seeds imported from China due to the detection of cyclamate levels that exceeded the permitted regulatory limits. The enforcement action specifically targeted the importer, Guangdong Import & Export, highlighting the rigorous compliance challenges companies face in the distribution of sweetener-containing snacks. This incident underscored the necessity for strict supply chain oversight and quality control among exporters and importers to ensure that products containing artificial sweeteners meet the precise safety standards of destination markets in Southeast Asia.
  • In March 2024, the regulatory framework for the global cyclamate market was strengthened when the National Health Commission of China released the updated National Food Safety Standard for the Uses of Food Additives (GB 2760-2024). This extensive regulatory update, which governs the production and application of sweeteners, reaffirmed the permitted usage levels of sodium cyclamate in key categories such as frozen drinks and canned fruits. The publication of this standard provided critical operational clarity for major domestic manufacturers, such as Golden Time Chemical, enabling them to align their production and quality assurance processes with the updated safety protocols ahead of the implementation deadline in early 2025.

Key Market Players

  • PT. Batang Alum Industrie
  • Food Chem International Corporation
  • Productos Aditivos
  • Rasna Private Limited
  • Hangzhou Garden Corporation
  • Shanghai Rich Chemicals
  • Jinan Haohua Industry Co. Ltd.
  • Hangzhou Union Biotechnology
  • Xuchang Ruida Biology Technology
  • Rainbow Rich Industrial Ltd

By Type

By End User Industry

By Region

  • Cyclamic Acid
  • Sodium Cyclamate
  • Calcium Cyclamate
  • Others
  • Food and Beverage
  • Healthcare
  • Cosmetics
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Cyclamate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Cyclamate Market, By Type:
  • Cyclamic Acid
  • Sodium Cyclamate
  • Calcium Cyclamate
  • Others
  • Cyclamate Market, By End User Industry:
  • Food and Beverage
  • Healthcare
  • Cosmetics
  • Others
  • Cyclamate Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cyclamate Market.

Available Customizations:

Global Cyclamate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Cyclamate Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Cyclamate Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Type (Cyclamic Acid, Sodium Cyclamate, Calcium Cyclamate, Others)

5.2.2.  By End User Industry (Food and Beverage, Healthcare, Cosmetics, Others)

5.2.3.  By Region

5.2.4.  By Company (2025)

5.3.  Market Map

6.    North America Cyclamate Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Type

6.2.2.  By End User Industry

6.2.3.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Cyclamate Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Type

6.3.1.2.2.  By End User Industry

6.3.2.    Canada Cyclamate Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Type

6.3.2.2.2.  By End User Industry

6.3.3.    Mexico Cyclamate Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Type

6.3.3.2.2.  By End User Industry

7.    Europe Cyclamate Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Type

7.2.2.  By End User Industry

7.2.3.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Cyclamate Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Type

7.3.1.2.2.  By End User Industry

7.3.2.    France Cyclamate Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Type

7.3.2.2.2.  By End User Industry

7.3.3.    United Kingdom Cyclamate Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Type

7.3.3.2.2.  By End User Industry

7.3.4.    Italy Cyclamate Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Type

7.3.4.2.2.  By End User Industry

7.3.5.    Spain Cyclamate Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Type

7.3.5.2.2.  By End User Industry

8.    Asia Pacific Cyclamate Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Type

8.2.2.  By End User Industry

8.2.3.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Cyclamate Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Type

8.3.1.2.2.  By End User Industry

8.3.2.    India Cyclamate Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Type

8.3.2.2.2.  By End User Industry

8.3.3.    Japan Cyclamate Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Type

8.3.3.2.2.  By End User Industry

8.3.4.    South Korea Cyclamate Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Type

8.3.4.2.2.  By End User Industry

8.3.5.    Australia Cyclamate Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Type

8.3.5.2.2.  By End User Industry

9.    Middle East & Africa Cyclamate Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Type

9.2.2.  By End User Industry

9.2.3.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Cyclamate Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Type

9.3.1.2.2.  By End User Industry

9.3.2.    UAE Cyclamate Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Type

9.3.2.2.2.  By End User Industry

9.3.3.    South Africa Cyclamate Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Type

9.3.3.2.2.  By End User Industry

10.    South America Cyclamate Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Type

10.2.2.  By End User Industry

10.2.3.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Cyclamate Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Type

10.3.1.2.2.  By End User Industry

10.3.2.    Colombia Cyclamate Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Type

10.3.2.2.2.  By End User Industry

10.3.3.    Argentina Cyclamate Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Type

10.3.3.2.2.  By End User Industry

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Cyclamate Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  PT. Batang Alum Industrie

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  Food Chem International Corporation

15.3.  Productos Aditivos

15.4.  Rasna Private Limited

15.5.  Hangzhou Garden Corporation

15.6.  Shanghai Rich Chemicals

15.7.  Jinan Haohua Industry Co. Ltd.

15.8.  Hangzhou Union Biotechnology

15.9.  Xuchang Ruida Biology Technology

15.10.  Rainbow Rich Industrial Ltd

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Cyclamate Market was estimated to be USD 2.08 Billion in 2025.

North America is the dominating region in the Global Cyclamate Market.

Food and Beverage segment is the fastest growing segment in the Global Cyclamate Market.

The Global Cyclamate Market is expected to grow at 3.66% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.